Anti-Parkinson's Drugs: Global Markets to 2022
Report Scope:
This research report categorizes the anti-Parkinson’s drugs market by type. Product types include low dopaminergic, dopamine agonists, enzyme inhibitors and other anti-Parkinson’s medications.
Report Includes:
- 95 data tables
- An overview of the global market for anti-Parkinson’s drugs and their future demand
- Analyses of global market trends, with data from 2013-2017, and projections of compound annual growth rates (CAGRs) through 2022
- Analyses of the major factors and technological advances such as biomarkers, 3D printed drugs, mobile applications and wearable technologies in the monitoring and treatment of Parkinson’s disease
- Discussion of the major segments of the anti-Parkinson’s drugs, i.e., dopaminergic drugs, dopamine agonists, enzyme inhibitors and other anti-Parkinson’s medications
- Company profiles of the major players in the market, including AbbVie, Mylan Laboratories, Valeant Pharmaceuticals and Novartis
- Chapter 1 Introduction
- Study Goals and Objectives
- Reasons for Doing This Study
- Scope of Report
- Information Sources
- Methodology
- Geographic Breakdown
- Analyst's Credentials
- Related BCC Research Reports
- Chapter 2 Summary and Highlights
- Chapter 3 Anti-Parkinson's Drugs Market Characteristics
- Chapter 4 Anti-Parkinson's Drugs Market Size and Growth
- Historic Market Growth
- Drivers of the Market
- Restraints on the Market
- Forecast Market Growth
- Drivers of the Market
- Restraints on the Market
- Chapter 5 Anti-Parkinson's Drugs Market Trends and Strategies
- New Medication to Help the Body Absorb Parkinson’s Disease Medication
- Free Water Biomarker to Track Changes in Brain
- 3D Printing Technology
- Chapter 6 PESTLE Analysis
- Political
- Government Financial Support
- Uncertain Political Policies
- Government Intervention
- Economic
- Wealth
- Globalization
- Emerging Markets
- Social
- Aging Global Population
- Health Consciousness and Awareness
- Traditional Medicine Continues to Pose Threat to Market
- Shortage of Skill
- Technological
- Technological Breakthroughs
- Wearable Technology and Hardware Advancements
- Internet Penetration and Mobile Applications
- Legal
- Stringent Regulations and Long Approval Procedures
- Tax Exemptions Initiatives and Subsidies
- Investment Regulations
- Environmental
- Chapter 7 Anti-Parkinson's Drugs Market Segmentation
- Global Anti-Parkinson's Drugs Market, by Segment
- Global Anti-Parkinson's Drugs Market, Historic and Forecast, by Segment, 2013-2022
- Dopaminergics Market
- Market Characteristics
- Market Trends and Strategies
- Dopamine Agonists Market
- Market Characteristics
- Market Trends and Strategies
- Enzyme Inhibitors Market
- Market Characteristics
- Market Trends and Strategies
- Other Anti-Parkinson's Medications Market
- Market Characteristics
- Chapter 8 Anti-Parkinson's Drugs Market Regional and Country Analysis
- Global Anti-Parkinson's Drugs Market, by Region
- Global Anti-Parkinson's Drugs Market, 2013-2022, Historic and Forecast, by Region
- Global Anti-Parkinson's Drugs Market Segmentation, by Region, 2017
- Global Anti-Parkinson's Drugs Market, by Country
- Global Anti-Parkinson's Drugs Market, Historic and Forecast, by Country
- Global Anti-Parkinson's Drugs Market Segmentation, 2017, by Country
- Chapter 9 Global Anti-Parkinson's Drugs Market Comparison with Macro Economic Factors
- Global Per Capita Average Anti-Parkinson's Drugs Market Expenditure
- Per Capita Average Anti-Parkinson's Drugs Market Expenditure, by Country
- Chapter 10 Asia-Pacific Anti-Parkinson's Drugs Market
- Asia-Pacific Anti-Parkinson's Drugs Market Overview
- Region Information
- Market Information
- Prevalence of Parkinson's Disease
- Government Initiatives
- Major Contracts/Research and Development Projects
- Regulatory Bodies
- Regulations
- Major Associations
- Export and Import Duties on Anti-Parkinson Drugs
- Taxes Levied
- Corporate Tax Structure
- Competitive Landscape
- Asia-Pacific Anti-Parkinson's Drugs Market Historic Market, 2013-2017
- Asia-Pacific Anti-Parkinson's Drugs Market Forecast Market
- Asia-Pacific Anti-Parkinson's Drugs Market, by Segment
- Asia-Pacific Anti-Parkinson's Drugs Market, Historic and Forecast CAGR, by Segment
- Chapter 11 Asia-Pacific Anti-Parkinson's Drugs Market: Country Analysis
- China Anti-Parkinson's Drugs Market Overview
- Country Information
- Market information
- Prevalence of Parkinson's Disease
- Government Initiatives
- Major Contracts/Research and development Projects
- Regulatory Bodies
- Regulations
- Major Associations
- Export and Import Duties on Anti-Parkinson Drugs
- Taxes Levied
- Corporate Tax Structure
- Competitive Landscape
- China Anti-Parkinson's Drugs Market Historic Market, 2013-2017
- China Anti-Parkinson's Drugs Market Forecast Market, 2017-2022
- China Market Size, by Segment
- China Anti-Parkinson's Drugs Market, 2013-2022, Historic and Forecast, by Segment
- India Anti-Parkinson's Drugs Market Overview
- Country Information
- Market Information
- Prevalence of Parkinson's Disease
- Government Initiatives
- Major Contracts/Research and Development Projects
- Regulatory Bodies
- Regulations
- Major Associations
- Import and Export Duties
- Taxes Levied
- Corporate Tax Structure
- Competitive Landscape
- India Anti-Parkinson's Drugs Market Historic Market, 2013-2017
- India Anti-Parkinson's Drugs Market Forecast Market, 2017-2022
- India Market Size, by Segment
- India Anti-Parkinson's Drugs Market, 2013-2022, Historic and Forecast, by Segment
- Japan Anti-Parkinson's Drugs Market Overview
- Country Information
- Market Information
- Prevalence of Parkinson's Disease
- Government Initiatives
- Major Contracts/Research and Development Projects
- Regulatory Bodies
- Regulations
- Major Associations
- Import and Export Duties on Anti-Parkinson Drugs
- Taxes Levied
- Corporate Tax Structure
- Competitive Landscape
- Japan Anti-Parkinson's Drugs Market Historic Market, 2013-2017
- Japan Anti-Parkinson's Drugs Market Forecast Market, 2017-2022
- Japan Market Size, by Segment
- Japan Anti-Parkinson's Drugs Market, 2013-2022, Historic and Forecast, by Segment
- Australia Anti-Parkinson's Drugs Market
- Australia Anti-Parkinson's Drugs Market Historic Market, 2013-2017
- Australia Anti-Parkinson's Drugs Market Forecast Market, 2017-2022
- Australia Market Size, by Segment
- Australia Anti-Parkinson's Drugs Market, 2013-2022, Historic and Forecast, by Segment
- Chapter 12 Western Europe Anti-Parkinson's Drugs Market
- Western European Anti-Parkinson's Drugs Market Overview
- Region Information
- Market Information
- Prevalence of Parkinson's Disease
- Government Initiatives
- Major Contracts/Research and Development Projects
- Regulatory Bodies
- Regulations
- Major Associations
- Taxes Levied
- Corporate Tax Structure
- Competitive Landscape
- Western Europe Anti-Parkinson's Drugs Historic Market, 2013-2017
- Western Europe Anti-Parkinson's Drugs Forecast Market, 2017-2022
- Western Europe Market Size, by Segment
- Western Europe Anti-Parkinson's Drugs Market, 2013-2022, Historic and Forecast, by Segment
- Chapter 13 Western Europe Anti-Parkinson's Drugs Market: Country Analysis
- UK Anti-Parkinson's Drugs Market Overview
- Country Information
- Market information
- Prevalence of Parkinson's Disease
- Government Initiatives
- Major Contracts/Research and Development Projects
- Regulatory Bodies
- Regulations
- Major Associations
- Export and Import Duties on Anti-Parkinson Drugs
- Taxes Levied
- Corporate Tax Structure
- Competitive Landscape
- UK Anti-Parkinson's Drugs Historic Market, 2013-2017
- UK Anti-Parkinson's Drugs Forecast Market, 2017-2022
- UK Market Size, by Segment
- UK Anti-Parkinson's Drugs Market, 2013-2022, Historic and Forecast, by Segment
- Germany Anti-Parkinson's Drugs Market
- Germany Anti-Parkinson's Drugs Historic Market, 2013-2017
- Germany Anti-Parkinson's Drugs Forecast Market, 2017-2022
- Germany Market Size, by Segment
- Germany Anti-Parkinson's Drugs Market, 2013-2022, Historic and Forecast, by Segment
- France Anti-Parkinson's Drugs Market
- France Anti-Parkinson's Drugs Market Historic Market, 2013-2017
- France Anti-Parkinson's Drugs Forecast Market, 2017-2022
- France Market Size, by Segment
- France Anti-Parkinson's Drugs Market, Historic and Forecast, by Segment, 2013-2022
- Italy Anti-Parkinson's Drugs Market
- Italy Anti-Parkinson's Drugs Market Historic Market, 2013-2017
- Italy Anti-Parkinson's Drugs Market Forecast Market, 2017-2022
- Italy Market Size, by Segment
- Italy Anti-Parkinson's Drugs Market, Historic and Forecast, by Segment, 2013-2022,
- Spain Anti-Parkinson's Drugs Market
- Spain Anti-Parkinson's Drugs Market Historic Market, 2013-2017
- Spain Anti-Parkinson's Drugs Forecast Market, 2017-2022
- Spain Market Size, by Segment
- Spain Anti-Parkinson's Drugs Market, Historic and Forecast, by Segment, 2013-2022
- Chapter 14 Eastern Europe Anti-Parkinson's Drugs Market
- Eastern European Anti-Parkinson's Drugs Market Overview
- Region Information
- Market Information
- Prevalence of Parkinson's Disease
- Government Initiatives
- Major Contracts/Research and Development Projects
- Regulatory Bodies
- Regulations
- Major Associations
- Export and Import Duties On Anti-Parkinson Drugs
- Taxes Levied
- Corporate Tax Structure
- Competitive Landscape
- Eastern Europe Anti-Parkinson's Drugs Historic Market, 2013-2017
- Eastern Europe Anti-Parkinson's Drugs Forecast Market, 2017-2022
- Eastern Europe Market Size, by Segment
- Eastern Europe Anti-Parkinson's Drugs Market, Historic and Forecast, by Segment, 2013-2022
- Chapter 15 Eastern Europe Anti-Parkinson's Drugs Market: Country Analysis
- Russia Anti-Parkinson's Drugs Market
- Russia Anti-Parkinson's Drugs Historic Market, 2013-2017
- Russia Anti-Parkinson's Drugs Forecast Market, 2017-2022
- Russia Market Size, by Segment
- Russia Anti-Parkinson's Drugs Market, Historic and Forecast, by Segment, 2013-2022
- Chapter 16 North America Anti-Parkinson's Drugs Market
- North America Anti-Parkinson's Drugs Market Overview
- Region Information
- Market Information
- Prevalence of Parkinson's Disease
- Government Initiatives
- Major Contracts/Research and Development Projects
- Regulatory Bodies
- Regulations
- Major Associations
- Taxes Levied
- Corporate Tax Structure
- Competitive Landscape
- North America Anti-Parkinson's Drugs Historic Market, 2013-2017
- North America Anti-Parkinson's Drugs Forecast Market, 2017-2022
- North America Market Size, by Segment
- North America Anti-Parkinson's Drugs Market, Historic and Forecast, by Segment, 2013-2022
- Chapter 17 North America Anti-Parkinson's Drugs Market: Country Analysis
- USA Anti-Parkinson's Drugs Market
- USA Anti-Parkinson's Drugs Market Historic Market, 2013-2017
- USA Anti-Parkinson's Drugs Market Forecast Market, 2017-2022
- USA Market Size, by Segment
- USA Anti-Parkinson's Drugs Market, 2013-2022, Historic and Forecast, by Segment
- Chapter 18 South America Anti-Parkinson's Drugs Market
- South America Anti-Parkinson's Drugs Market Overview
- Region Information
- Market Information
- Prevalence of Parkinson's Disease
- Government Initiatives
- Major Contracts/Research and Development Projects
- Regulatory Bodies
- Regulations
- Major Associations
- Taxes Levied
- Corporate Tax Structure
- Competitive Landscape
- South America Anti-Parkinson's Drugs Historic Market, 2013-2017
- South America Anti-Parkinson's Drugs Forecast Market, 2017-2022
- South America Market Size, by Segment
- South America Anti-Parkinson's Drugs Historic and Forecast Market, by Segment, 2013-2022
- Chapter 19 South America Anti-Parkinson's Drugs Market: Country Analysis
- Brazil Anti-Parkinson's Drugs Market
- Brazil Anti-Parkinson's Drugs Historic Market, 2013-2016
- Brazil Anti-Parkinson's Drugs Market Forecast Market, 2017-2022
- Brazil Market Size, by Segment
- Brazil Anti-Parkinson's Drugs Historic and Forecast Market, by Segment, 2013-2022
- Chapter 20 Middle East Anti-Parkinson's Drugs Market
- Middle Anti-Parkinson's Drugs Market Overview
- Region Information
- Market information
- Prevalence of Parkinson's Disease
- Government Initiatives
- Major Contracts/Research and Development Projects
- Regulations
- Regulatory Bodies
- Major Associations
- Competitive Landscape
- Middle East Anti-Parkinson's Drugs Historic Market, 2013-2017
- Middle East Anti-Parkinson's Drugs Forecast Market, 2017-2022
- Middle East Market Size, by Segment
- Middle East Anti-Parkinson's Drugs Historic and Forecast Market, by Segment, 2013-2022
- Chapter 21 Africa Anti-Parkinson's Drugs Market
- Africa Anti-Parkinson's Drugs Market Overview
- Region Information
- Market information
- Prevalence of Parkinson's Disease
- Government Initiatives
- Regulatory Bodies
- Major Associations
- Export and Import Duties on Anti-Parkinson Drugs
- Competitive Landscape
- Africa Anti-Parkinson's Drugs Historic Market, 2013-2017
- Africa Anti-Parkinson's Drugs Forecast Market, 2017-2022
- Africa Market Size, by Segment
- Africa Anti-Parkinson's Drugs Historic and Forecast Market, by Segment, 2013-2022
- Chapter 22 Anti-Parkinson's Drugs Market Customer Information
- Significant Impact of Parkinson's Disease on Quality of Life
- Knowledge Gaps among Parkinson's Patients and Caregivers
- Parkinson's Awareness in UK
- Knowledge on Parkinson's Disease among Patients and General Neurologists
- Power of Placebo
- Chapter 23 Anti-Parkinson's Drugs Market Competitive Landscape
- Company Profiles
- ABBVIE
- BOEHRINGER INGELHEIM
- F. HOFFMANN-LA ROCHE AG
- NOVARTIS AG
- UCB SA
- Chapter 24 Key Mergers and Acquisitions in the Anti-Parkinson's Drugs Market
- Teva Pharmaceutical Acquired Auspex Pharmaceuticals
- Mitsubishi Tanabe Acquired NeuroDerm
- Sunovion Pharmaceuticals Acquired Cynapsus Therapeutics
- Acorda Therapeutics Acquired Civitas Therapeutics
- Acorda Therapeutics Acquired Biotie Therapies
- Chapter 25 Appendix
- Definitions of the Industry
- Anti-Parkinson's Drugs
- Research Methodology
- Chapter 26 References
- List of Tables
- Summary Table : Global Anti-Parkinson’s Drugs Forecast Market, Through 2022
- Table 1 : Global Anti-Parkinson’s Drugs Historic Market, Through 2017
- Table 2 : Global Anti-Parkinson’s Drugs Forecast Market, Through 2022
- Table 3 : Global Anti-Parkinson’s Drugs Market, by Segment, 2017
- Table 4 : Global Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
- Table 5 : Global Anti-Parkinson’s Drugs Market, by Region, 2017
- Table 6 : Global Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Region, 2013-2022
- Table 7 : Global Anti-Parkinson’s Drugs Market Segmentation, by Region, 2017
- Table 8 : Global Anti-Parkinson’s Drugs Market, by Country, 2017
- Table 9 : Global Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Country, 2013-2022
- Table 10 : Global Anti-Parkinson’s Drugs Market Segmentation, by Country, 2017
- Table 11 : Global Per Capita Average Anti-Parkinson’s Drugs Market Expenditure, 2013–2022
- Table 12 : Per Capita Average Anti-Parkinson’s Drugs Market Expenditure, by Country, 2017
- Table 13 : Asia-Pacific-Anti-Parkinson’s Drugs Historic Market, Through 2017
- Table 14 : Asia-Pacific Anti-Parkinson’s Drugs Forecast Market, Through 2022
- Table 15 : Asia-Pacific Anti-Parkinson’s Drugs Market, by Segment, 2017
- Table 16 : Asia-Pacific Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
- Table 17 : China Anti-Parkinson’s Drugs Historic Market, Through 2017
- Table 18 : China Anti-Parkinson’s Drugs Forecast Market, Through 2022
- Table 19 : China Anti-Parkinson’s Drugs Market, by Segment, 2017
- Table 20 : China Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
- Table 21 : India Anti-Parkinson’s Drugs Historic Market, Through 2017
- Table 22 : India Anti-Parkinson’s Drugs Forecast Market, Through 2022
- Table 23 : India Anti-Parkinson’s Drugs Market, by Segment, 2017
- Table 24 : India Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
- Table 25 : Japan Anti-Parkinson’s Drugs Historic Market, Through 2017
- Table 26 : Japan Anti-Parkinson’s Drugs Forecast Market, Through 2022
- Table 27 : Japan Anti-Parkinson’s Drugs Market, by Segment, 2017
- Table 28 : Japan Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
- Table 29 : Australia Anti-Parkinson’s Drugs Historic Market, Through 2017
- Table 30 : Australia Anti-Parkinson’s Drugs Forecast Market, Through 2022
- Table 31 : Australia Anti-Parkinson’s Drugs Market, by Segment, 2017
- Table 32 : Australia Anti-Parkinson’s Drugs Market Historic and Forecast Growth Rate, by Segment, 2013-2022
- Table 33 : Western Europe Anti-Parkinson’s Drugs Historic Market, Through 2017
- Table 34 : Western Europe Anti-Parkinson’s Drugs Forecast Market, Through 2022
- Table 35 : Western Europe Anti-Parkinson’s Drugs Market, by Segment, 2017
- Table 36 : Western Europe Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
- Table 37 : UK Anti-Parkinson’s Drugs Historic Market, Through 2017
- Table 38 : UK Anti-Parkinson’s Drugs Forecast Market, Through 2022
- Table 39 : UK Anti-Parkinson’s Drugs Market, by Segment, 2017
- Table 40 : UK Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
- Table 41 : Germany Anti-Parkinson’s Drugs Historic Market, Through 2017
- Table 42 : Germany Anti-Parkinson’s Drugs Forecast Market, Through 2022,
- Table 43 : Germany Anti-Parkinson’s Drugs Market, by Segment, 2017
- Table 44 : Germany Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
- Table 45 : France Anti-Parkinson’s Drugs Historic Market, Through 2017
- Table 46 : France Anti-Parkinson’s Drugs Forecast Market, Through 2022
- Table 47 : France Anti-Parkinson’s Drugs Market, by Segment, 2017
- Table 48 : France Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
- Table 49 : Italy Anti-Parkinson’s Drugs Historic Market, Through 2017
- Table 50 : Italy Anti-Parkinson’s Drugs Forecast Market, Through 2022
- Table 51 : Italy Anti-Parkinson’s Drugs Market, by Segment, 2017
- Table 52 : Italy Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
- Table 53 : Spain Anti-Parkinson’s Drugs Historic Market, Through 2017
- Table 54 : Spain Anti-Parkinson’s Drugs Forecast Market, Through 2022
- Table 55 : Spain Anti-Parkinson’s Drugs Market, by Segment, 2017
- Table 56 : Spain Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
- Table 57 : Eastern Europe Anti-Parkinson’s Drugs Historic Market, Through 2017
- Table 58 : Eastern Europe Anti-Parkinson’s Drugs Forecast Market, Through 2022
- Table 59 : Eastern Europe Anti-Parkinson’s Drugs Market, by Segment, 2017
- Table 60 : Eastern Europe Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
- Table 61 : Russia Anti-Parkinson’s Drugs Historic Market, Through 2017
- Table 62 : Russia Anti-Parkinson’s Drugs Forecast Market, Through 2022
- Table 63 : Russia Anti-Parkinson’s Drugs Market, by Segment, 2017
- Table 64 : Russia Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
- Table 65 : North America Anti-Parkinson’s Drugs Historic Market, Through 2017
- Table 66 : North America Anti-Parkinson’s Drugs Forecast Market, Through 2022
- Table 67 : North America Anti-Parkinson’s Drugs Market, by Segment, 2017
- Table 68 : North America Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
- Table 69 : USA Anti-Parkinson’s Drugs Historic Market, Through 2017
- Table 70 : USA Anti-Parkinson’s Drugs Forecast Market, Through 2022
- Table 71 : USA Anti-Parkinson’s Drugs Market, by Segment, 2017
- Table 72 : USA Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
- Table 73 : South America Anti-Parkinson’s Drugs Historic Market, Through 2017
- Table 74 : South America Anti-Parkinson’s Drugs Forecast Market, Through 2022
- Table 75 : South America Anti-Parkinson’s Drugs Market, by Segment, 2017
- Table 76 : South America Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
- Table 77 : Brazil Anti-Parkinson’s Drugs Historic Market, Through 2017
- Table 78 : Brazil Anti-Parkinson’s Drugs Forecast Market, Through 2022
- Table 79 : Brazil Anti-Parkinson’s Drugs Market, by Segment, 2017
- Table 80 : Brazil Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
- Table 81 : Middle East Anti-Parkinson’s Drugs Historic Market, Through 2017
- Table 82 : Middle East Anti-Parkinson’s Drugs Forecast Market, Through 2022
- Table 83 : Middle East Anti-Parkinson’s Drugs Market, by Segment, 2017
- Table 84 : Middle East Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
- Table 85 : Africa Anti-Parkinson’s Drugs Historic Market, Through 2017
- Table 86 : Africa Anti-Parkinson’s Drugs Forecast Market, Through 2022
- Table 87 : Africa Anti-Parkinson’s Drugs Market, by Segment, 2017
- Table 88 : Africa Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
- Table 89 : Global Market Share for Key Competitors of Anti-Parkinson’s Drugs, 2017
- Table 90 : AbbVie, Inc.: Financial Performance, 2013-2017
- Table 91 : Boehringer Ingelheim: Financial Performance, 2013-2016
- Table 92 : F. Hoffmann-La Roche: Financial Performance, 2013-2017
- Table 93 : Novartis AG: Financial Performance, 2013-2017
- Table 94 : UCB SA: Financial Performance, 2013-2017
- Table 95 : Market Data Sources
- List of Figures
- Summary Figure : Global Anti-Parkinson’s Drugs Forecast Market, 2017-2022
- Figure 1 : Global Anti-Parkinson's Drugs Historic Market, 2013-2017
- Figure 2 : Global Anti-Parkinson's Drugs Forecast Market, 2017-2022
- Figure 3 : PESTLE Analysis: Global Anti-Parkinson’s Drugs Market, 2017
- Figure 4 : Global Anti-Parkinson’s Drugs Market Share, by Segment, 2017
- Figure 5 : Global Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
- Figure 6 : Global Anti-Parkinson’s Drugs Market Share, by Region, 2017
- Figure 7 : Global Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Region, 2013-2022
- Figure 8 : Global Anti-Parkinson’s Drugs Market Segmentation, by Region, 2017,
- Figure 9 : Global Anti-Parkinson’s Drugs Market Share, by Country, 2017
- Figure 10 : Global Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Country, 2013-2022
- Figure 11 : Global Anti-Parkinson’s Drugs Market Segmentation, by Country, 2017
- Figure 12 : Global Per Capita Average Anti-Parkinson’s Drugs Market Expenditure, 2013–2022
- Figure 13 : Asia-Pacific Anti-Parkinson’s Drugs Historic Market, 2013-2017
- Figure 14 : Asia-Pacific Anti-Parkinson’s Drugs Forecast Market, 2017-2022
- Figure 15 : Asia-Pacific Anti-Parkinson’s Drugs Market, by Segment, 2017
- Figure 16 : Asia-Pacific Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
- Figure 17 : China Anti-Parkinson’s Drugs Historic Market, 2013-2017
- Figure 18 : China Anti-Parkinson’s Drugs Forecast Market, 2017-2022
- Figure 19 : China Anti-Parkinson’s Drugs Market Share, by Segment, 2017
- Figure 20 : China Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
- Figure 21 : India Anti-Parkinson’s Drugs Historic Market, 2013-2017
- Figure 22 : India Anti-Parkinson’s Drugs Forecast Market, 2017-2022
- Figure 23 : India Anti-Parkinson’s Drugs Market, by Segment, 2017
- Figure 24 : India Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
- Figure 25 : Japan Anti-Parkinson’s Drugs Historic Market, 2013-2017
- Figure 26 : Japan Anti-Parkinson’s Drugs Forecast Market, 2017-2022
- Figure 27 : Japan Anti-Parkinson’s Drugs Market, by Segment, 2017
- Figure 28 : Japan Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
- Figure 29 : Australia Anti-Parkinson’s Drugs Historic Market, 2013-2017
- Figure 30 : Australia Anti-Parkinson’s Drugs Forecast Market, 2017-2022
- Figure 31 : Australia Anti-Parkinson’s Drugs Market Share, by Segment, 2017
- Figure 32 : Australia Anti-Parkinson’s Drugs Market, by Segment, 2017
- Figure 33 : Western Europe Anti-Parkinson’s Drugs Historic Market, 2013-2017
- Figure 34 : Western Europe Anti-Parkinson’s Drugs Forecast Market, 2017-2022
- Figure 35 : Western Europe Anti-Parkinson’s Drugs Market, by Segment, 2017
- Figure 36 : Western Europe Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
- Figure 37 : UK Anti-Parkinson’s Drugs Historic Market, 2013-2017
- Figure 38 : UK Anti-Parkinson’s Drugs Forecast Market, 2017-2022
- Figure 39 : UK Anti-Parkinson’s Drugs Market, by Segment, 2017
- Figure 40 : UK Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
- Figure 41 : Germany Anti-Parkinson’s Drugs Historic Market, 2013-2017
- Figure 42 : Germany Anti-Parkinson’s Drugs Forecast Market, 2017-2022
- Figure 43 : Germany Anti-Parkinson’s Drugs Market, by Segment, 2017
- Figure 44 : Germany Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
- Figure 45 : France Anti-Parkinson’s Drugs Historic Market, 2013-2017
- Figure 46 : France Anti-Parkinson’s Drugs Forecast Market, 2017-2022
- Figure 47 : France Anti-Parkinson’s Drugs Market, by Segment, 2017
- Figure 48 : France Anti-Parkinson’s Drugs Historic and Forecast Growth Rate Market, by Segment, 2013-2022
- Figure 49 : Italy Anti-Parkinson’s Drugs Historic Market, 2013-2017
- Figure 50 : Italy Anti-Parkinson’s Drugs Forecast Market, 2017-2022
- Figure 51 : Italy Anti-Parkinson’s Drugs Market, by Segment, 2017
- Figure 52 : Italy Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
- Figure 53 : Spain Anti-Parkinson’s Drugs Historic Market, 2013-2017
- Figure 54 : Spain Anti-Parkinson’s Drugs Forecast Market, 2017-2022
- Figure 55 : Spain Anti-Parkinson’s Drugs Market, by Segment, 2017
- Figure 56 : Spain Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
- Figure 57 : Eastern Europe Anti-Parkinson’s Drugs Historic Market, 2013-2017
- Figure 58 : Eastern Europe Anti-Parkinson’s Drugs Forecast Market, 2017-2022
- Figure 59 : Eastern Europe Anti-Parkinson’s Drugs Market, by Segment, 2017
- Figure 60 : Eastern Europe Anti-Parkinson’s Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
- Figure 61 : Russia Anti-Parkinson’s Drugs Historic Market, 2013-2017
- Figure 62 : Russia Anti-Parkinson’s Drugs Forecast Market, 2017-2022
- Figure 63 : Russia Anti-Parkinson’s Drugs Market, by Segment, 2017
- Figure 64 : Russia Anti-Parkinson’s Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
- Figure 65 : North America Anti-Parkinson’s Drugs Historic Market, 2013-2017
- Figure 66 : North America Anti-Parkinson’s Drugs Forecast Market, 2017-2022
- Figure 67 : North America Anti-Parkinson’s Drugs Market, by Segment, 2017
- Figure 68 : North America Anti-Parkinson’s Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
- Figure 69 : USA Anti-Parkinson’s Drugs Historic Market, 2013-2017
- Figure 70 : USA Anti-Parkinson’s Drugs Forecast Market, 2017-2022
- Figure 71 : USA Anti-Parkinson’s Drugs Market, by Segment, 2017
- Figure 72 : USA Anti-Parkinson’s Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
- Figure 73 : South America Anti-Parkinson’s Drugs Historic Market, 2013-2017
- Figure 74 : South America Anti-Parkinson’s Drugs Forecast Market, 2017-2022
- Figure 75 : South America Anti-Parkinson’s Drugs Market, by Segment, 2017
- Figure 76 : South America Anti-Parkinson’s Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
- Figure 77 : Brazil Anti-Parkinson’s Drugs Historic Market, 2013-2017
- Figure 78 : Brazil Anti-Parkinson’s Drugs Forecast Market, 2017-2022
- Figure 79 : Brazil Anti-Parkinson’s Drugs Market, by Segment, 2017
- Figure 80 : Brazil Anti-Parkinson’s Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
- Figure 81 : Middle East Anti-Parkinson’s Drugs Historic Market, 2013-2017
- Figure 82 : Middle East Anti-Parkinson’s Drugs Forecast Market, 2017-2022
- Figure 83 : Middle East Anti-Parkinson’s Drugs Market, by Segment, 2017
- Figure 84 : Middle East Anti-Parkinson’s Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
- Figure 85 : Africa Anti-Parkinson’s Drugs Historic Market, 2013-2017
- Figure 86 : Africa Anti-Parkinson’s Drugs Forecast Market, 2017-2022
- Figure 87 : Africa Anti-Parkinson’s Drugs Market, by Segment, 2017
- Figure 88 : Africa Anti-Parkinson’s Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
- Figure 89 : Global Market Share for Key Competitors of Anti-Parkinson’s Drugs, 2017,
- Figure 90 : AbbVie Inc.: Financial Performance, 2013-2017
- Figure 91 : Boehringer Ingelheim: Financial Performance, 2013-2016
- Figure 92 : F. Hoffmann-La Roche: Financial Performance, 2013-2017
- Figure 93 : Novartis AG: Financial Performance, 2013-2017
- Figure 94 : UCB SA: Financial Performance, 2013-2017
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook